首页 > 最新文献

Arkhiv patologii最新文献

英文 中文
[SARS-CoV-2-induced non-bacterial endomyocarditis with the development of acquired heart defects]. [sars - cov -2诱导的非细菌性心内膜炎伴获得性心脏缺损的发展]。
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.17116/patol20238506152
O V Blagova, E A Kogan, E V Pavlenko, A V Sedov, Yu V Lerner, S V Chernyavskij

Patients with damage of the mitral, aortic and tricuspid valves and systolic myocardial dysfunction associated with previous SARS-CoV-2 infection are described. The diagnosis of acquired defect was established in 4 patients based on medical history, electrocardiography, echocardiography, magnetic resonance imaging of the heart, endomyocardial or intraoperative myocardial biopsy, and in one case, autopsy. The study of the myocardium included H&E, Van Gieson staining, immunohistochemical (IHC) study with antibodies to CD3, CD20, CD45, CD68, to the nucleocapsid and Spike proteins of SARS-CoV-2. Previous valve diseases (prolapse, bicuspid aortic valve) served as a background for the development of the defect in 2 patients. In all cases, IHC studies revealed coronavirus proteins, lymphocytic endocarditis and myocarditis, moderate fibrosis, and signs of connective tissue disorganization. High titers of anticardiac antibodies indicated an autoimmune mechanism for carditis. No signs of infective endocarditis or thromboembolic complications were identified in any case. In patients with an unclear nature of valvular heart defects, a previous new coronavirus infection should be identified and taken into account as a possible etiological factor. The simultaneous development of lymphocytic myocarditis significantly increases the risk of surgical intervention on the valves and requires an integrated approach to treatment.

描述了与既往SARS-CoV-2感染相关的二尖瓣、主动脉瓣和三尖瓣损伤和收缩期心肌功能障碍患者。4例患者通过病史、心电图、超声心动图、心脏磁共振成像、心内膜或术中心肌活检,1例通过尸检确定获得性缺损的诊断。心肌组织的研究包括H&E、Van Gieson染色、免疫组化(IHC)和CD3、CD20、CD45、CD68抗体,以及SARS-CoV-2的核衣壳和刺突蛋白抗体。既往瓣膜疾病(脱垂,二尖瓣主动脉瓣)是2例患者发生瓣膜缺损的背景。在所有病例中,免疫组化研究显示冠状病毒蛋白、淋巴细胞性心内膜炎和心肌炎、中度纤维化和结缔组织紊乱的迹象。抗心脏抗体的高滴度表明心脏炎的自身免疫机制。在任何情况下,没有发现感染性心内膜炎或血栓栓塞并发症的迹象。对于性质不明的瓣膜性心脏缺陷患者,应确认既往新型冠状病毒感染,并考虑其可能的病因。同时发展的淋巴细胞性心肌炎显著增加手术干预瓣膜的风险,需要综合治疗方法。
{"title":"[SARS-CoV-2-induced non-bacterial endomyocarditis with the development of acquired heart defects].","authors":"O V Blagova, E A Kogan, E V Pavlenko, A V Sedov, Yu V Lerner, S V Chernyavskij","doi":"10.17116/patol20238506152","DOIUrl":"10.17116/patol20238506152","url":null,"abstract":"<p><p>Patients with damage of the mitral, aortic and tricuspid valves and systolic myocardial dysfunction associated with previous SARS-CoV-2 infection are described. The diagnosis of acquired defect was established in 4 patients based on medical history, electrocardiography, echocardiography, magnetic resonance imaging of the heart, endomyocardial or intraoperative myocardial biopsy, and in one case, autopsy. The study of the myocardium included H&E, Van Gieson staining, immunohistochemical (IHC) study with antibodies to CD3, CD20, CD45, CD68, to the nucleocapsid and Spike proteins of SARS-CoV-2. Previous valve diseases (prolapse, bicuspid aortic valve) served as a background for the development of the defect in 2 patients. In all cases, IHC studies revealed coronavirus proteins, lymphocytic endocarditis and myocarditis, moderate fibrosis, and signs of connective tissue disorganization. High titers of anticardiac antibodies indicated an autoimmune mechanism for carditis. No signs of infective endocarditis or thromboembolic complications were identified in any case. In patients with an unclear nature of valvular heart defects, a previous new coronavirus infection should be identified and taken into account as a possible etiological factor. The simultaneous development of lymphocytic myocarditis significantly increases the risk of surgical intervention on the valves and requires an integrated approach to treatment.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"85 6","pages":"52-61"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138443684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Vasculogenic mimicry]. (Vasculogenic模仿)。
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.17116/patol20238506162
E Z Lapkina, A R Esimbekova, T G Ruksha

Anti-angiogenic drugs are used as an established approach of malignant neoplasms therapy. It has been established that the development of the phenomenon of vasculogenic mimicry - a specific variant of tumor neoangiogenesis, which is formed in highly aggressive solid tumors, is associated with a decrease in the effectiveness of antitumor therapy. This review highlights the mechanisms of development of vasculogenic mimicry in malignant neoplasms, which is one of the alternative options for tumor blood supply. In the formation of vasculogenic mimicry, an important role is assigned to the tumor microenvironment, primarily tumor-associated macrophages and fibroblasts. The signaling pathways that regulate the formation of vasculogenic mimicry channels in tumors have been characterized. The prospects for a targeted impact on molecular targets that initiate and promote vasculogenic mimicry, the impact on which can increase the effectiveness of antitumor therapy, are shown. The review discusses experimental studies of the mechanisms of vasculogenic mimicry formation in malignant neoplasms and the prospects for targeted action on molecules that are components of signaling cascades involved in the development of this model of neoangiogenesis.

抗血管生成药物是恶性肿瘤治疗的既定方法。已经确定,在高度侵袭性实体肿瘤中形成的血管生成模仿现象(一种肿瘤新生血管生成的特定变体)的发展与抗肿瘤治疗有效性的降低有关。本文综述了恶性肿瘤中血管源性模拟的发展机制,这是肿瘤血液供应的替代选择之一。在血管模拟的形成中,肿瘤微环境,主要是肿瘤相关的巨噬细胞和成纤维细胞,起着重要的作用。调控肿瘤血管生成模拟通道形成的信号通路已被表征。对启动和促进血管生成模拟的分子靶标的靶向影响的前景,可以增加抗肿瘤治疗的有效性。本文讨论了恶性肿瘤血管生成模拟形成机制的实验研究,以及对参与这种新血管生成模型发展的信号级联分子的靶向作用的前景。
{"title":"[Vasculogenic mimicry].","authors":"E Z Lapkina, A R Esimbekova, T G Ruksha","doi":"10.17116/patol20238506162","DOIUrl":"10.17116/patol20238506162","url":null,"abstract":"<p><p>Anti-angiogenic drugs are used as an established approach of malignant neoplasms therapy. It has been established that the development of the phenomenon of vasculogenic mimicry - a specific variant of tumor neoangiogenesis, which is formed in highly aggressive solid tumors, is associated with a decrease in the effectiveness of antitumor therapy. This review highlights the mechanisms of development of vasculogenic mimicry in malignant neoplasms, which is one of the alternative options for tumor blood supply. In the formation of vasculogenic mimicry, an important role is assigned to the tumor microenvironment, primarily tumor-associated macrophages and fibroblasts. The signaling pathways that regulate the formation of vasculogenic mimicry channels in tumors have been characterized. The prospects for a targeted impact on molecular targets that initiate and promote vasculogenic mimicry, the impact on which can increase the effectiveness of antitumor therapy, are shown. The review discusses experimental studies of the mechanisms of vasculogenic mimicry formation in malignant neoplasms and the prospects for targeted action on molecules that are components of signaling cascades involved in the development of this model of neoangiogenesis.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"85 6","pages":"62-69"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138443688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The role of mast cells in physiological and complicated pregnancy]. 肥大细胞在生理和复杂妊娠中的作用。
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.17116/patol20238503175
M V Shamarakova, N V Nizyaeva, I M Bogdanova, M N Boltovskaya, K A Artemyeva, L M Mikhaleva

Mast cells (MCs) are highly differentiated and multifunctional immune cells. The importance of TC has been established not only as mediators of allergic reactions, but also for the development of an immune response, the occurrence of certain autoimmune diseases, tissue homeostasis, the formation of immunotolerance and metastasis of malignant tumors. MCs are present in the endometrium of women in various value depending on age, the phase of the menstrual cycle, the presence of pregnancy. Out of pregnancy, MCs are involved in the cyclic transformation of the uterine mucosa. At the onset of pregnancy, MCs stimulate the process of remodeling of the spiral arteries, the production of leukemia-inhibiting factor (LIF), which is the main implantation factor, and contribute to the formation of an immunotolerant state of the mother in relation to the fetus. Obstetric complications are accompanied by a variable content of MCs, which is associated with different genesis of diseases. A low amount of MCs is associated with impaired implantation and the development of early preeclampsia, an increased content of MCs is observed in the presence of a pathological inflammatory reaction that accompanies late preeclampsia. This review is devoted to the significance of MCs and their mediators in the physiological course of pregnancy, as well as their participation in the pathogenetic mechanisms of pregnancy complications.

肥大细胞是一种高度分化的多功能免疫细胞。TC不仅作为过敏反应的介质,而且在免疫反应的发展、某些自身免疫性疾病的发生、组织稳态、免疫耐受的形成和恶性肿瘤的转移等方面具有重要作用。MCs存在于女性的子宫内膜中,根据年龄、月经周期的阶段、是否怀孕而有不同的价值。妊娠期外,MCs参与子宫黏膜的循环转化。在怀孕初期,MCs刺激螺旋动脉的重塑过程,产生白血病抑制因子(LIF),这是主要的植入因子,并有助于形成与胎儿相关的母亲免疫耐受状态。产科并发症伴随着MCs的不同含量,这与不同的疾病起源有关。MCs含量低与植入受损和早期子痫前期的发展有关,在晚期子痫前期的病理性炎症反应中观察到MCs含量增加。本文就MCs及其介质在妊娠生理过程中的重要作用及其参与妊娠并发症的发病机制作一综述。
{"title":"[The role of mast cells in physiological and complicated pregnancy].","authors":"M V Shamarakova,&nbsp;N V Nizyaeva,&nbsp;I M Bogdanova,&nbsp;M N Boltovskaya,&nbsp;K A Artemyeva,&nbsp;L M Mikhaleva","doi":"10.17116/patol20238503175","DOIUrl":"https://doi.org/10.17116/patol20238503175","url":null,"abstract":"<p><p>Mast cells (MCs) are highly differentiated and multifunctional immune cells. The importance of TC has been established not only as mediators of allergic reactions, but also for the development of an immune response, the occurrence of certain autoimmune diseases, tissue homeostasis, the formation of immunotolerance and metastasis of malignant tumors. MCs are present in the endometrium of women in various value depending on age, the phase of the menstrual cycle, the presence of pregnancy. Out of pregnancy, MCs are involved in the cyclic transformation of the uterine mucosa. At the onset of pregnancy, MCs stimulate the process of remodeling of the spiral arteries, the production of leukemia-inhibiting factor (LIF), which is the main implantation factor, and contribute to the formation of an immunotolerant state of the mother in relation to the fetus. Obstetric complications are accompanied by a variable content of MCs, which is associated with different genesis of diseases. A low amount of MCs is associated with impaired implantation and the development of early preeclampsia, an increased content of MCs is observed in the presence of a pathological inflammatory reaction that accompanies late preeclampsia. This review is devoted to the significance of MCs and their mediators in the physiological course of pregnancy, as well as their participation in the pathogenetic mechanisms of pregnancy complications.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"85 3","pages":"75-81"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9577855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Differential diagnosis of IgG4-related disease]. 【igg4相关疾病的鉴别诊断】。
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.17116/patol20238502160
A A Timakova, S G Radenska-Lopovok

IgG4-related disease is a chronic autoimmune fibro-inflammatory disease characterized by the presence of lymphoplasmacytic infiltrate, storiform fibrosis, obliterating phlebitis, increased number of IgG4+ cells in tissue, and, in most cases, an elevated serum IgG4 level. This disease often affects the pancreas, salivary glands and lymph nodes, but can involve almost any tissue. Its etiology is still unclear, the central role in the pathogenesis belongs to B-lymphocytes, T2-helpers, interleukins 1-β, 4, 5, 10, 13 and tumor growth factor 1-β. The ambiguous clinical picture and frequent simultaneous involvement of several organs make it difficult to diagnose, so biopsy plays a leading role in making a diagnosis. The characteristic microscopic picture, the presence of certain populations of lymphocytes are key criteria in establishing the correct diagnosis.

IgG4相关疾病是一种慢性自身免疫性纤维炎症性疾病,其特征是存在淋巴浆细胞浸润、故事状纤维化、闭塞性静脉炎、组织中IgG4+细胞数量增加,并且在大多数情况下,血清IgG4水平升高。这种疾病通常影响胰腺、唾液腺和淋巴结,但几乎可以涉及任何组织。其病因尚不清楚,在发病机制中起核心作用的是b淋巴细胞、t2辅助细胞、白细胞介素1-β、4、5、10、13和肿瘤生长因子1-β。临床表现模糊,多脏器同时受累,诊断困难,故活检在诊断中起主导作用。特征性的显微镜图像,某些淋巴细胞群的存在是建立正确诊断的关键标准。
{"title":"[Differential diagnosis of IgG4-related disease].","authors":"A A Timakova,&nbsp;S G Radenska-Lopovok","doi":"10.17116/patol20238502160","DOIUrl":"https://doi.org/10.17116/patol20238502160","url":null,"abstract":"<p><p>IgG4-related disease is a chronic autoimmune fibro-inflammatory disease characterized by the presence of lymphoplasmacytic infiltrate, storiform fibrosis, obliterating phlebitis, increased number of IgG4+ cells in tissue, and, in most cases, an elevated serum IgG4 level. This disease often affects the pancreas, salivary glands and lymph nodes, but can involve almost any tissue. Its etiology is still unclear, the central role in the pathogenesis belongs to B-lymphocytes, T2-helpers, interleukins 1-β, 4, 5, 10, 13 and tumor growth factor 1-β. The ambiguous clinical picture and frequent simultaneous involvement of several organs make it difficult to diagnose, so biopsy plays a leading role in making a diagnosis. The characteristic microscopic picture, the presence of certain populations of lymphocytes are key criteria in establishing the correct diagnosis.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"85 2","pages":"60-65"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9664915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Chronic gastric ulcer in a child not diagnosed during life]. [未确诊的儿童慢性胃溃疡]。
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.17116/patol20238503171
A P Nadeev, M A Karpov, M A Travin

Chronic gastric ulcer is a rare disease in childhood. The article presents data on the epidemiology and etiology of the disease in children, describes the case of a chronic gastric ulcer complicated by penetration into the liver, perforation, development of abdominal sepsis, with a fatal outcome in a 7-year-old girl.

慢性胃溃疡是一种罕见的儿童疾病。这篇文章介绍了儿童疾病的流行病学和病因学数据,描述了慢性胃溃疡并发渗透到肝脏,穿孔,腹部败血症发展的病例,致命的结果在一个7岁的女孩。
{"title":"[Chronic gastric ulcer in a child not diagnosed during life].","authors":"A P Nadeev,&nbsp;M A Karpov,&nbsp;M A Travin","doi":"10.17116/patol20238503171","DOIUrl":"https://doi.org/10.17116/patol20238503171","url":null,"abstract":"<p><p>Chronic gastric ulcer is a rare disease in childhood. The article presents data on the epidemiology and etiology of the disease in children, describes the case of a chronic gastric ulcer complicated by penetration into the liver, perforation, development of abdominal sepsis, with a fatal outcome in a 7-year-old girl.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"85 3","pages":"71-74"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9949913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Issues of legal responsibility of the pathologist]. 病理学家的法律责任问题。
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.17116/patol20238504165
V S Chirsky, I V Timofeev, P G Malkov

Medical care refers to a risky type of activity, since as a result of its provision, harm to the patient's health may be caused and prerequisites for the onset of legal (civil, disciplinary, administrative and criminal) liability may arise. The legal liability of a pathologist in the event of an incorrect diagnosis by the attending physician on the basis of an incorrect conclusion of the pathologist may occur due to violations due to low qualifications, frivolity, negligence, failure to comply with the rules, procedures for providing medical care, job descriptions, official duties. If the incorrect conclusion of the pathologist was of an objective nature (for example, in the case of an incorrect interpretation of a diagnostically difficult case), it should go beyond the scope of punishable shortcomings in the activities of the pathologist. The financial responsibility of a pathologist may occur when its burden is placed on a medical organization for harm caused to the life or health of a patient, due to the establishment, among other things, of the legality of the actions (inaction) of a medical worker with whom the medical organization is in an employment relationship. A medical organization, in case of satisfaction of the patient's claims by the court, as a rule, in a regression procedure, may involve the relevant medical worker who caused the harm in the issue of compensation, compensate for their financial and reputational losses. The most important thing in such cases is to resolve the issue of establishing the grounds for bringing a medical worker to responsibility.

医疗保健是一种有风险的活动,因为提供医疗保健可能对病人的健康造成损害,并可能产生法律(民事、纪律、行政和刑事)责任的先决条件。如果主治医生根据病理学家的错误结论作出错误诊断,病理学家的法律责任可能是由于资历低、轻浮、疏忽、未能遵守提供医疗服务的规则、程序、工作描述、公务等违规行为造成的。如果病理学家的错误结论是客观的(例如,在对诊断困难的病例的错误解释的情况下),它应该超出病理学家活动中应受惩罚的缺点的范围。当医疗组织因与该医疗组织有雇佣关系的医务工作者的行为(不作为)的合法性而使病理学家承担损害病人生命或健康的负担时,病理学家的经济责任就可能发生。医疗机构在法院满足患者要求的情况下,通常在回归程序中,可以让造成伤害的相关医务工作者参与赔偿问题,赔偿其经济和名誉损失。在这种情况下,最重要的是解决追究医务工作者责任的理由问题。
{"title":"[Issues of legal responsibility of the pathologist].","authors":"V S Chirsky,&nbsp;I V Timofeev,&nbsp;P G Malkov","doi":"10.17116/patol20238504165","DOIUrl":"https://doi.org/10.17116/patol20238504165","url":null,"abstract":"<p><p>Medical care refers to a risky type of activity, since as a result of its provision, harm to the patient's health may be caused and prerequisites for the onset of legal (civil, disciplinary, administrative and criminal) liability may arise. The legal liability of a pathologist in the event of an incorrect diagnosis by the attending physician on the basis of an incorrect conclusion of the pathologist may occur due to violations due to low qualifications, frivolity, negligence, failure to comply with the rules, procedures for providing medical care, job descriptions, official duties. If the incorrect conclusion of the pathologist was of an objective nature (for example, in the case of an incorrect interpretation of a diagnostically difficult case), it should go beyond the scope of punishable shortcomings in the activities of the pathologist. The financial responsibility of a pathologist may occur when its burden is placed on a medical organization for harm caused to the life or health of a patient, due to the establishment, among other things, of the legality of the actions (inaction) of a medical worker with whom the medical organization is in an employment relationship. A medical organization, in case of satisfaction of the patient's claims by the court, as a rule, in a regression procedure, may involve the relevant medical worker who caused the harm in the issue of compensation, compensate for their financial and reputational losses. The most important thing in such cases is to resolve the issue of establishing the grounds for bringing a medical worker to responsibility.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"85 4","pages":"65-69"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9981216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Lung pathology in post-covid syndrome]. [新冠肺炎后综合征的肺部病理学]。
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.17116/patol20238505152
S N Bugrov, I V Dvorakovskaya, B M Ariel

The clinic and pathological anatomy of the infection caused by the SARS-CoV-2 virus (coronavirus infection - CI) with the development of Post-Covid syndrome (PS) have not been studied enough. This also applies to morphofunctional changes in the lungs, one of the most important components of PS. We conducted a histological and bacterioscopic study of lung biopsy specimens in 20 patients of both sexes aged 22-75 years. In many patients, PS developed relatively late - not earlier than 1 year - 1 year 4 months after the onset of acute clinical symptoms of CI. Structural changes in the lungs in PS appear as an inflammatory reaction such as interstitial pneumonia. Most patients had nonspecific interstitial pneumonia with elements of organizing interstitial pneumonia, in some cases complicated by the presence of a specific granulomatous reaction, characteristic of pulmonary tuberculosis. Despite this, according to the results of traditional bacterioscopic and bacteriological studies, the tuberculous etiology of pulmonary fibrosis has not yet been confirmed. Perhaps this is due to the fact that we are talking about an inapparent tuberculosis infection, the causative agent of which is the L-form of Mycobacterium tuberculosis. Patients with PS who have pulmonary fibrosis on x-ray should be under the special supervision of a phthisiatrician or pulmonologist.

严重急性呼吸系统综合征冠状病毒2型病毒(冠状病毒感染-CI)引起的感染伴随着感染后综合征(PS)的发展,其临床和病理解剖尚未得到足够的研究。这也适用于肺的形态功能变化,肺是PS最重要的组成部分之一。我们对20名22-75岁的男女患者的肺活检标本进行了组织学和细菌学研究。在许多患者中,PS的发展相对较晚,不早于CI急性临床症状发作后1年-1年4个月。PS肺部的结构变化表现为炎症反应,如间质性肺炎。大多数患者患有非特异性间质性肺炎,并伴有组织性间质性疾病,在某些情况下,还伴有肺结核特有的肉芽肿性反应。尽管如此,根据传统的细菌学和细菌学研究结果,肺纤维化的结核病因尚未得到证实。也许这是因为我们谈论的是一种隐性结核病感染,其病原体是结核分枝杆菌的L型。在x光检查中患有肺纤维化的PS患者应在肺结核学家或肺科医生的特别监督下。
{"title":"[Lung pathology in post-covid syndrome].","authors":"S N Bugrov,&nbsp;I V Dvorakovskaya,&nbsp;B M Ariel","doi":"10.17116/patol20238505152","DOIUrl":"10.17116/patol20238505152","url":null,"abstract":"<p><p>The clinic and pathological anatomy of the infection caused by the SARS-CoV-2 virus (coronavirus infection - CI) with the development of Post-Covid syndrome (PS) have not been studied enough. This also applies to morphofunctional changes in the lungs, one of the most important components of PS. We conducted a histological and bacterioscopic study of lung biopsy specimens in 20 patients of both sexes aged 22-75 years. In many patients, PS developed relatively late - not earlier than 1 year - 1 year 4 months after the onset of acute clinical symptoms of CI. Structural changes in the lungs in PS appear as an inflammatory reaction such as interstitial pneumonia. Most patients had nonspecific interstitial pneumonia with elements of organizing interstitial pneumonia, in some cases complicated by the presence of a specific granulomatous reaction, characteristic of pulmonary tuberculosis. Despite this, according to the results of traditional bacterioscopic and bacteriological studies, the tuberculous etiology of pulmonary fibrosis has not yet been confirmed. Perhaps this is due to the fact that we are talking about an inapparent tuberculosis infection, the causative agent of which is the L-form of Mycobacterium tuberculosis. Patients with PS who have pulmonary fibrosis on x-ray should be under the special supervision of a phthisiatrician or pulmonologist.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"85 5","pages":"52-59"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41181930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oleko Dmitrievich Mishnev. (On the occasion of the 80th anniversary of his birth) 奥列科·德米特里耶维奇·米什涅夫。(在他诞辰80周年之际)
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.17116/patol20238504184
{"title":"Oleko Dmitrievich Mishnev. (On the occasion of the 80th anniversary of his birth)","authors":"","doi":"10.17116/patol20238504184","DOIUrl":"https://doi.org/10.17116/patol20238504184","url":null,"abstract":"","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67406942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Sclerosing mucoepidermoid carcinoma with eosinophilia of thyroid gland]. 甲状腺嗜酸性粒细胞增多的硬化性黏液表皮样癌。
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.17116/patol20238506147
A Yu Abrosimov, E V Bondarenko, D A Pastuhova, M E Beloshitsky

Sclerosing mucoepidermoid carcinoma with stromal eosinophilia of thyroid gland is represented less than 100 cases in the world literature. We present a rare case of sclerosing mucoepidermoid carcinona with stromal eosinophilia in a 69-year-old woman who has been observed for multinodular goiter for more than 3 years. Cytological examination revealed a picture most of all corresponding to a malignant neoplasm (Bethesda V). The patient underwent a thyroidectomy. Pathomorphological examination revealed a neoplasm of mixed structure with foci of cribriform structures and squamous metaplasia with areas of keratinization. According to the IHC study, the expression of TTF-1, p63, cytokeratins 5/6 were positive, while there were no expression of thyroglobulin with its positive reaction in the thyroid tissue. Additional histochemical staining with Alcian blue revealed a positive reaction with a homogeneous acellular substance of the tumor. A comprehensive morphological study with the use of additional stains made it possible to accurately establish the diagnosis, which will determine the further tactics of managing the patient.

在世界文献中,甲状腺硬化性黏液表皮样癌伴间质嗜酸性粒细胞增多的病例不足100例。我们报告一例罕见的硬化性黏液表皮样癌伴间质嗜酸性粒细胞增多的病例,患者为69岁的女性,因多结节性甲状腺肿而被观察超过3年。细胞学检查显示的图像大部分与恶性肿瘤相对应(Bethesda V)。患者接受了甲状腺切除术。病理形态学检查显示一混合结构的肿瘤,有筛状结构和鳞状化生伴角化区。免疫组化研究显示TTF-1、p63、细胞角蛋白5/6表达阳性,甲状腺组织未见甲状腺球蛋白阳性表达。另外用阿利新蓝进行组织化学染色,发现肿瘤与一种均匀的脱细胞物质呈阳性反应。使用额外的染色进行全面的形态学研究,可以准确地建立诊断,这将决定管理患者的进一步策略。
{"title":"[Sclerosing mucoepidermoid carcinoma with eosinophilia of thyroid gland].","authors":"A Yu Abrosimov, E V Bondarenko, D A Pastuhova, M E Beloshitsky","doi":"10.17116/patol20238506147","DOIUrl":"10.17116/patol20238506147","url":null,"abstract":"<p><p>Sclerosing mucoepidermoid carcinoma with stromal eosinophilia of thyroid gland is represented less than 100 cases in the world literature. We present a rare case of sclerosing mucoepidermoid carcinona with stromal eosinophilia in a 69-year-old woman who has been observed for multinodular goiter for more than 3 years. Cytological examination revealed a picture most of all corresponding to a malignant neoplasm (Bethesda V). The patient underwent a thyroidectomy. Pathomorphological examination revealed a neoplasm of mixed structure with foci of cribriform structures and squamous metaplasia with areas of keratinization. According to the IHC study, the expression of TTF-1, p63, cytokeratins 5/6 were positive, while there were no expression of thyroglobulin with its positive reaction in the thyroid tissue. Additional histochemical staining with Alcian blue revealed a positive reaction with a homogeneous acellular substance of the tumor. A comprehensive morphological study with the use of additional stains made it possible to accurately establish the diagnosis, which will determine the further tactics of managing the patient.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"85 6","pages":"47-51"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138443685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Causes of death in the Moscow region according to medical death certificates]. [根据医学死亡证明,莫斯科地区的死亡原因]。
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.17116/patol20238501129
E P Kakorina, I V Samorodskaya, T K Chernyavskaya

Objective: Determination of the leading causes of death based on data from primary medical death certificates (MDCs) depending on the place of death.

Material and methods: From the electronic database of the Main Department of the Civil Registry Office of the Moscow Region (the USR registry office system) for 2021, all cases were selected in which diseases were indicated as the primary cause of death (PCD); all codes of external causes, injuries and poisonings were excluded. A total of 109.126 cases, 50.6% died in the hospital, 34% died at home, and 16.4% died elsewhere. Bureau of Forensic Medical Examination (BFME) issued 45.2% of MSS. Taking into account the frequency of use of ICD codes, the clinical similarity of individual codes, 20 groups were formed, which accounted for 90.1% of deaths from diseases.

Results: The frequency of registration of individual groups of causes of death largely depends on the place of death. 5 leading groups of causes of death were established: 1) in general from COVID-19 23.55%, chronic ischemic heart disease (CIHD-1) without postinfarction cardiosclerosis, aneurysm and ischemic cardiomyopathy (CMP) 14.5%, from encephalopathy indefinite (EI) 11.4%, malignant neoplasms (MN) 11.3%, stroke 6.2%; 2) in a hospital from COVID-19 45%, stroke 10%, MN 8.3%; CIHD-1 7.1%, CIHD with a history of MI/ischemic CMP 2.7%; 3) at home from CIHD-1 21.8%, EI 21.5%, MN 15.5%, from diseases associated with alcohol 3.3% and brain cyst 3.3%; 4) elsewhere from CIHD-1 22.7%, EI 21.6%, MN 12%, from other forms of acute coronary artery disease 5.4%, alcohol-associated diseases 4.8%. Acute MI ranked 6th among deaths in general - 2.7%. PCD is also associated with the place of issue of the MDCs - 90% of the MDC with the indication of EI and «other degenerative diseases of the nervous system» as the cause of death were issued by the BFME. Not a single MDC issued by the BFME contained such PCDs as "old age" or "brain cyst".

Conclusion: The nosological structure of the causes of death and the issuance of individual ICD codes in the MDC as a PCD varies significantly depending on the place of death and the issuance of the MDC. The reasons need to be further clarified. The use of codes that are not permitted for use has been registered.

目的:根据主要医疗死亡证明(MDCs)的数据,根据死亡地点确定主要死亡原因。材料和方法:从2021年莫斯科州民事登记办公室(USR登记办公室系统)主要部门的电子数据库中选择所有病例,其中疾病被指定为主要死亡原因(PCD);所有外因、伤害和中毒的代码都被排除在外。共109.126例,其中医院死亡50.6%,家中死亡34%,其他地方死亡16.4%。法医检验局签发了45.2%的MSS。考虑到ICD编码的使用频率、个体编码的临床相似性,共形成20组,占疾病死亡人数的90.1%。结果:各组死亡原因的登记频率在很大程度上取决于死亡地点。确定5组主要死亡原因:1)一般死于新冠肺炎23.55%,无梗死后心硬化、动脉瘤和缺血性心肌病(CMP)的慢性缺血性心脏病(CIHD-1) 14.5%,不明确脑病(EI) 11.4%,恶性肿瘤(MN) 11.3%,脑卒中6.2%;2)住院时患COVID-19的占45%,卒中占10%,MN占8.3%;CIHD-1 7.1%,伴有MI/缺血性CMP病史的CIHD 2.7%;3)家中来自CIHD-1的21.8%,EI的21.5%,MN的15.5%,酒精相关疾病的3.3%,脑囊肿的3.3%;4)其他来自CIHD-1的22.7%,EI 21.6%, MN 12%,其他形式的急性冠状动脉疾病5.4%,酒精相关疾病4.8%。急性心肌梗死在总死亡人数中排名第六,占2.7%。PCD还与疾病诊断证明书的签发地有关——90%的疾病诊断证明书显示,EI和"其他神经系统退行性疾病"是由疾病诊断和诊断局签发的死因。BFME发布的MDC中没有一个包含诸如“老年”或“脑囊肿”之类的PCDs。结论:死亡原因的分科结构和MDC作为PCD的个人ICD代码的签发,因死亡地点和MDC的签发而有显着差异。原因需要进一步澄清。对不允许使用的代码进行了注册。
{"title":"[Causes of death in the Moscow region according to medical death certificates].","authors":"E P Kakorina,&nbsp;I V Samorodskaya,&nbsp;T K Chernyavskaya","doi":"10.17116/patol20238501129","DOIUrl":"https://doi.org/10.17116/patol20238501129","url":null,"abstract":"<p><strong>Objective: </strong>Determination of the leading causes of death based on data from primary medical death certificates (MDCs) depending on the place of death.</p><p><strong>Material and methods: </strong>From the electronic database of the Main Department of the Civil Registry Office of the Moscow Region (the USR registry office system) for 2021, all cases were selected in which diseases were indicated as the primary cause of death (PCD); all codes of external causes, injuries and poisonings were excluded. A total of 109.126 cases, 50.6% died in the hospital, 34% died at home, and 16.4% died elsewhere. Bureau of Forensic Medical Examination (BFME) issued 45.2% of MSS. Taking into account the frequency of use of ICD codes, the clinical similarity of individual codes, 20 groups were formed, which accounted for 90.1% of deaths from diseases.</p><p><strong>Results: </strong>The frequency of registration of individual groups of causes of death largely depends on the place of death. 5 leading groups of causes of death were established: 1) in general from COVID-19 23.55%, chronic ischemic heart disease (CIHD-1) without postinfarction cardiosclerosis, aneurysm and ischemic cardiomyopathy (CMP) 14.5%, from encephalopathy indefinite (EI) 11.4%, malignant neoplasms (MN) 11.3%, stroke 6.2%; 2) in a hospital from COVID-19 45%, stroke 10%, MN 8.3%; CIHD-1 7.1%, CIHD with a history of MI/ischemic CMP 2.7%; 3) at home from CIHD-1 21.8%, EI 21.5%, MN 15.5%, from diseases associated with alcohol 3.3% and brain cyst 3.3%; 4) elsewhere from CIHD-1 22.7%, EI 21.6%, MN 12%, from other forms of acute coronary artery disease 5.4%, alcohol-associated diseases 4.8%. Acute MI ranked 6<sup>th</sup> among deaths in general - 2.7%. PCD is also associated with the place of issue of the MDCs - 90% of the MDC with the indication of EI and «other degenerative diseases of the nervous system» as the cause of death were issued by the BFME. Not a single MDC issued by the BFME contained such PCDs as \"old age\" or \"brain cyst\".</p><p><strong>Conclusion: </strong>The nosological structure of the causes of death and the issuance of individual ICD codes in the MDC as a PCD varies significantly depending on the place of death and the issuance of the MDC. The reasons need to be further clarified. The use of codes that are not permitted for use has been registered.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"85 1","pages":"29-35"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10750093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Arkhiv patologii
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1